LivaNova (LIVN) Non Operating Interest Expenses (2015 - 2026)
LivaNova's (LIVN) quarterly Non Operating Interest Expenses came in at $7.2 million in Q2 2026, down 51.94% year-over-year from $14.9 million in Q2 2025, and down 13.45% quarter-over-quarter from $8.3 million in Q1 2026.
Analysis
LivaNova (LIVN) Non Operating Interest Expenses (2015 - 2026) Analysis & Trends
LivaNova has disclosed Non Operating Interest Expenses across 12 years of filings, most recently posting $7.2 million for Q2 2026.
- In Q2 2026, Non Operating Interest Expenses fell 51.94% year-over-year to $7.2 million; the TTM figure through Jun 2026 stood at $37.2 million (down 39.89% YoY), while the FY2025 annual figure was $49.3 million, down 21.86% from the prior year.
- Non Operating Interest Expenses came in at $7.2 million for Q2 2026 at LivaNova, down from $8.3 million in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $15.9 million in Q1 2024 to a low of $7.2 million in Q2 2026.
- Average Non Operating Interest Expenses over 5 years is $13.2 million, with a median of $14.6 million recorded in 2022.
- Year-over-year, Non Operating Interest Expenses jumped 110.58% in 2022 and tumbled 51.94% in 2026.
- Over 5 years, Non Operating Interest Expenses stood at $13.4 million in 2022, then grew by 16.91% to $15.6 million in 2023, then advanced by 0.93% to $15.8 million in 2024, then tumbled by 31.14% to $10.9 million in 2025, then sank by 33.9% to $7.2 million in 2026.
- Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $7.2 million in Q2 2026, $8.3 million in Q1 2026, and $10.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.80 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 7.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.18 Mn |
| Mar 31, 2026 | 8.29 Mn |
| Dec 31, 2025 | 10.86 Mn |
| Sep 30, 2025 | 10.86 Mn |
| Jun 30, 2025 | 14.93 Mn |
| Mar 31, 2025 | 15.29 Mn |
| Dec 31, 2024 | 15.77 Mn |
| Sep 30, 2024 | 15.88 Mn |
| Jun 30, 2024 | 15.53 Mn |
| Mar 31, 2024 | 15.89 Mn |
| Dec 31, 2023 | 15.62 Mn |
| Sep 30, 2023 | 14.99 Mn |
| Jun 30, 2023 | 14.81 Mn |
| Mar 31, 2023 | 13.44 Mn |
| Dec 31, 2022 | 13.36 Mn |
| Sep 30, 2022 | 12.66 Mn |
| Jun 30, 2022 | 14.39 Mn |
| Mar 31, 2022 | 7.84 Mn |
| Dec 31, 2021 | 6.35 Mn |
| Sep 30, 2021 | 11.36 Mn |